These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4135678)

  • 1. [Letter: Nycturia in prostatic hypertrophy].
    Sigel A
    Dtsch Med Wochenschr; 1974 Aug; 99(31):1606. PubMed ID: 4135678
    [No Abstract]   [Full Text] [Related]  

  • 2. Night-time polyuria and nocturia.
    Matthiesen TB; Rittig S; Nørgaard JP; Pedersen EB; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1995; 173():81-2. PubMed ID: 8719574
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical diagnosis of benign prostatic hyperplasia].
    Homma Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():327-32. PubMed ID: 12599594
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urodynamic evaluation of aged patients with prostatism].
    Arena G; Laudi M; Novasio R; Fiore L; Sesia G
    Minerva Urol; 1983; 35(4):285-8. PubMed ID: 6201707
    [No Abstract]   [Full Text] [Related]  

  • 6. Guideline for the primary care management of male lower urinary tract symptoms.
    Speakman MJ; Kirby RS; Joyce A; Abrams P; Pocock R;
    BJU Int; 2004 May; 93(7):985-90. PubMed ID: 15142148
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on tolterodine for men with benign prostatic hyperplasia and lower urinary tract symptoms.
    O'Leary MP
    J Urol; 2008 May; 179(5 Suppl):S86. PubMed ID: 18405764
    [No Abstract]   [Full Text] [Related]  

  • 8. The urodynamic assessment of benign prostatic hyperplasia obstruction.
    Artibani W
    J Urol (Paris); 1995; 101(1):42-4. PubMed ID: 7545728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems with urination?].
    Hansen BJ
    Ugeskr Laeger; 1996 May; 158(21):2999-3000. PubMed ID: 8686043
    [No Abstract]   [Full Text] [Related]  

  • 10. Benign prostatic hyperplasia (BHP) and bothersome voiding symptoms.
    Hald T
    J Urol (Paris); 1995; 101(1):7-9. PubMed ID: 7545735
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urination disorder due to prostatic hypertrophy and its management].
    Kawamura J
    Kango Gijutsu; 1986 Jun; 32(8):945-8. PubMed ID: 2426494
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of prostatic nycturia with standardized extractum radix urticae].
    Stahl HP
    ZFA (Stuttgart); 1984 Jan; 60(3):128-32. PubMed ID: 6201019
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etiology of nocturia and clinical efficacy of naftopidil on nocturia in patients with benign prostatic hyperplasia--analysis of frequency volume charts].
    Masuda M; Nakayama K; Hiromoto Y; Hirokawa M; Satomi Y; Shiramizu M; Furuhata A; Ikeda A; Kawasaki C
    Hinyokika Kiyo; 2004 May; 50(5):309-14. PubMed ID: 15237482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating symptoms and functional status in benign prostate hyperplasia.
    O'Leary MP
    Br J Urol; 1995 Jul; 76 Suppl 1():25-8. PubMed ID: 7544212
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic dysfunction and male pelvic health.
    Kaplan SA
    Eur Urol; 2007 Aug; 52(2):316-7. PubMed ID: 17452073
    [No Abstract]   [Full Text] [Related]  

  • 16. [The objective of medical treatment: relieve the symptoms or stop the course?].
    Desgrandchamps F
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():14-6. PubMed ID: 16649585
    [No Abstract]   [Full Text] [Related]  

  • 17. Nighttime urination.
    Harv Mens Health Watch; 2002 Jul; 6(12):6-8. PubMed ID: 12138029
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study of the physical properties of the prostate (second report)--the relationships between dysuria and the strength of the surgical capsule in benign prostatic hypertrophy].
    Ohnishi K
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1388-99. PubMed ID: 2433485
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment on: The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement.
    Meuleman EJ
    Eur Urol; 2007 Oct; 52(4):1193-4. PubMed ID: 17293024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.